Skip to main navigation Skip to search Skip to main content

A Phase II, Open Label, Multicenter Study Of Olinvacimab In Combination with Pembrolizumab In Patients With Metastatic Triple-Negative Breast Cancer

  • White, Michelle (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date30/09/21 → 29/09/26

Keywords

  • phase 2 study
  • treatment safety
  • treatment efficacy
  • breast cancer
  • multicentre trial

Clinical Trial Phase

  • Phase II